COX/iNOS dependence for angiotensin-II-induced endothelial dysfunction

Peptides. 2022 Nov:157:170863. doi: 10.1016/j.peptides.2022.170863. Epub 2022 Aug 24.

Abstract

Vascular dysfunction induced by angiotensin-II can result from direct effects on vascular and inflammatory cells and indirect hemodynamic effects. Using isolated and functional cultured aortas, we aimed to identify the effects of angiotensin-II on cyclooxygenase (COX) and inducible nitric oxide synthase (iNOS) and evaluate their impact on vascular reactivity. Aortic rings from mice were incubated overnight in culture medium containing angiotensin-II (100 nmol/L) or vehicle to induce vascular disfunction. Vascular reactivity of cultured arteries was evaluated in a bath chamber. Immunofluorescence staining for COX-1 and COX-2 was performed. Nitric oxide (NO) formation was approached by the levels of nitrite, a NO end product, and using a fluorescent probe (DAF). Oxidative and nitrosative stress were determined by DHE fluorescence and nitrotyrosine staining, respectively. Arteries cultured with angiotensin-II showed impairment of endothelium-dependent relaxation, which was reversed by the AT1 receptor antagonist. Inhibition of COX and iNOS restored vascular relaxation, suggesting a common pathway in which angiotensin-II triggers COX and iNOS, leading to vasoconstrictor receptors activation. Moreover, using selective antagonists, TP and EP were identified as the receptors involved in this response. Endothelium-dependent contractions of angiotensin-II-cultured aortas were blunted by ibuprofen, and increased COX-2 immunostaining was found in the arteries, indicating endothelium release of vasoconstrictor prostanoids. Angiotensin-II induced increased reactive oxygen species and NO production. An iNOS inhibitor prevented NO enhancement and nitrotyrosine accumulation in arteries stimulated with angiotensin-II. These results confirm that angiotensin-II causes vascular inflammation that culminates in endothelial dysfunction in an iNOS and COX codependent manner.

Keywords: Angiotensin-II; Cyclooxygenase; EDCFs; Endothelial dysfunction; INOS; Nitrotyrosine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II* / metabolism
  • Angiotensin II* / pharmacology
  • Animals
  • Cyclooxygenase 2
  • Endothelium, Vascular
  • Fluorescent Dyes / pharmacology
  • Ibuprofen / pharmacology
  • Mice
  • Nitric Oxide Synthase Type II / metabolism
  • Nitric Oxide* / metabolism
  • Nitrites / metabolism
  • Nitrites / pharmacology
  • Prostaglandins
  • Reactive Oxygen Species / metabolism
  • Vasoconstrictor Agents / pharmacology

Substances

  • Fluorescent Dyes
  • Nitrites
  • Prostaglandins
  • Reactive Oxygen Species
  • Vasoconstrictor Agents
  • Angiotensin II
  • Nitric Oxide
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • Ibuprofen